PNEUMONIA PANEL BY FILM ARRAY (BIOFIRE)

Pneumonia Panel by FilmArray (BioFire) is an advanced multiplex molecular diagnostic test designed for comprehensive detection of pathogens responsible for pneumonia and lower respiratory tract infections. Using BioFire FilmArray technology, the test simultaneously identifies multiple bacteria, viruses, atypical organisms, and selected antimicrobial resistance genes from a single respiratory specimen within a short turnaround time.

Pneumonia is a serious respiratory infection that affects the lungs and may lead to severe complications if not diagnosed and treated promptly. Because bacterial, viral, and atypical pathogens can produce similar symptoms, rapid laboratory identification is essential for accurate diagnosis and effective treatment planning.

Benefits of the Test

• Rapid detection of multiple pneumonia-causing pathogens.
• Identifies bacteria, viruses, and atypical organisms simultaneously.
• Detects selected antimicrobial resistance markers.
• Provides highly sensitive and accurate molecular diagnosis.
• Supports targeted antimicrobial therapy.
• Reduces unnecessary antibiotic exposure.
• Helps manage severe respiratory infections effectively.
• Improves patient outcomes through early diagnosis.

Why Doctors Recommend This Test

Doctors recommend this test for patients with suspected pneumonia, severe lower respiratory tract infections, persistent cough, fever, breathing difficulty, intensive care admissions, ventilator-associated respiratory infections, or when rapid pathogen identification is critical for treatment decisions.

The test helps clinicians determine the exact infectious cause of pneumonia and identify potential antimicrobial resistance markers, supporting evidence-based patient management.

Preparation Before Test

• No fasting is required.
• Sputum, bronchoalveolar lavage fluid, tracheal aspirate, or lower respiratory tract specimens may be collected.
• Inform your doctor about ongoing antibiotic treatment.
• Follow all sample collection instructions carefully.
• Provide relevant clinical history and symptoms.
• Ensure prompt transportation of the specimen to the laboratory.

Normal Reporting Time

Most Pneumonia Panel by FilmArray (BioFire) reports at Focus Diagnostics are available within 2–3 hours after specimen processing. The advanced multiplex platform enables rapid pathogen identification significantly faster than conventional culture methods.

Who Should Take This Test?

This test may be recommended for:

• Patients with suspected bacterial or viral pneumonia.
• Individuals with severe lower respiratory tract infections.
• Hospitalized patients with respiratory illness.
• ICU patients with suspected pneumonia.
• Patients on ventilator support.
• Immunocompromised individuals.
• Elderly patients and high-risk populations.
• Patients requiring comprehensive respiratory pathogen analysis.

Detailed Information

Pneumonia remains one of the leading causes of hospitalization and mortality worldwide. It can be caused by a wide variety of bacterial, viral, fungal, and atypical pathogens. Traditional diagnostic approaches often require multiple laboratory tests and may take several days to provide complete results. Rapid pathogen identification is crucial because delayed diagnosis can lead to disease progression, prolonged hospitalization, and increased healthcare costs.

The BioFire FilmArray Pneumonia Panel is an advanced multiplex Polymerase Chain Reaction (PCR) platform capable of detecting numerous respiratory pathogens simultaneously. The system automates sample preparation, nucleic acid extraction, amplification, and detection, allowing comprehensive analysis from a single specimen with minimal hands-on laboratory time.

The panel is designed to detect a broad range of pathogens associated with lower respiratory tract infections. Depending on the specific panel configuration, detectable organisms may include Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter species, Legionella pneumophila, Mycoplasma pneumoniae, respiratory viruses, and other clinically significant pathogens.

A major advantage of the BioFire Pneumonia Panel is its ability to identify selected antimicrobial resistance genes. Detection of resistance markers helps clinicians select more appropriate antibiotic therapies and supports antimicrobial stewardship initiatives aimed at reducing antibiotic resistance.

This test is particularly valuable for critically ill patients, intensive care unit admissions, ventilator-associated pneumonia cases, immunocompromised individuals, transplant recipients, cancer patients, and patients with severe community-acquired or hospital-acquired pneumonia. Early and accurate diagnosis can significantly improve treatment outcomes and reduce complications.

The panel also supports infection control efforts by rapidly identifying infectious pathogens and helping healthcare providers implement appropriate preventive measures when necessary. Results should always be interpreted in conjunction with clinical findings, imaging studies, microbiology cultures, and other laboratory investigations.

At Focus Diagnostics, Pneumonia Panel by FilmArray (BioFire) testing is performed using state-of-the-art molecular diagnostic technology, advanced BioFire multiplex PCR systems, and rigorous quality assurance standards to provide accurate, reliable, and clinically meaningful results for respiratory infection diagnosis and management.